Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy$dstudy protocol of the TRADE-hypo trial - Bozorgmehr, Farastuk; Chung, Inn; Christopoulos, Petros; Krisam, Johannes; Schneider, Marc; Brückner, Lena Marie; Müller, Daniel Wilhelm; Thomas, Michael; Rieken, Stefan (BMC cancer, 2023)
Gesehen am 23.07.2024